RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Lessons learned from National Heart, Lung, and Blood Institute Covid-19 Clinical Trials
Thomas, S. M., Harrington, R. A., Yancy, C. W., Nugent, D., Erzurum, S., Bernard, G. R., Cushman, M., Hochman, J. S., Ridker, P. M., Ortel, T. L., Collins, S. P., Callaway, C. W., Nolen, T. L., Womack, K. N., Brown, S. M., Gelijns, A., Geraci, M., Ginde, A. A., Key, N. S., ... Patterson, A. P. (2024). Lessons learned from National Heart, Lung, and Blood Institute Covid-19 Clinical Trials. NEJM evidence, 3(11). https://doi.org/10.1056/EVIDctcs2300291
AbstractIn response to the Covid-19 pandemic, the National Heart, Lung, and Blood Institute launched five multisite clinical trials testing candidate host tissue-directed medical interventions to hasten recovery, improve function, and reduce morbidity and mortality. Speed, flexibility, and collaboration were essential. This article from the Steering and Executive committees describes the Collaborating Network of Networks for Evaluating Covid-19 and Therapeutic Strategies (CONNECTS) research program that enrolled 6690 participants and evaluated 18 intervention strategies using 10 molecular agents across the care continuum (outpatient, inpatient, and post discharge), and reports lessons learned from this initiative. Successes include rapid trial execution through collaboration and adaptive platform designs. Challenges that impeded efficiency included time required to execute subcontracts, constraints on clinical research workforce, and limited research infrastructure in nonacademic settings.
